EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 236 filers reported holding EMERGENT BIOSOLUTIONS INC in Q4 2019. The put-call ratio across all filers is 4.70 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $20,905,000 | +26.1% | 225,000 | +21.6% | 0.05% | +26.8% |
Q4 2020 | $16,576,000 | -23.6% | 185,000 | -11.9% | 0.04% | -38.8% |
Q3 2020 | $21,699,000 | +16.8% | 210,000 | -10.6% | 0.07% | 0.0% |
Q2 2020 | $18,584,000 | +10.8% | 235,000 | -19.0% | 0.07% | -18.3% |
Q1 2020 | $16,779,000 | +7.2% | 290,000 | 0.0% | 0.08% | +36.7% |
Q4 2019 | $15,645,000 | +3.2% | 290,000 | 0.0% | 0.06% | -3.2% |
Q3 2019 | $15,161,000 | +60.9% | 290,000 | +48.7% | 0.06% | +63.2% |
Q2 2019 | $9,420,000 | +72.7% | 195,000 | +80.6% | 0.04% | +65.2% |
Q1 2019 | $5,456,000 | +53.4% | 108,000 | +80.0% | 0.02% | +27.8% |
Q4 2018 | $3,557,000 | -9.9% | 60,000 | 0.0% | 0.02% | +12.5% |
Q3 2018 | $3,950,000 | +30.4% | 60,000 | 0.0% | 0.02% | +23.1% |
Q2 2018 | $3,029,000 | +27.9% | 60,000 | +33.3% | 0.01% | +18.2% |
Q1 2018 | $2,369,000 | +13.3% | 45,000 | 0.0% | 0.01% | +10.0% |
Q4 2017 | $2,091,000 | – | 45,000 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
AIMZ Investment Advisors, LLC | 52,590 | $621 | 0.29% |
Values First Advisors, Inc. | 33,942 | $400,858 | 0.28% |
PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. | 91,000 | $1,075,000 | 0.23% |
SummerHaven Investment Management, LLC | 25,347 | $299,348 | 0.18% |
PALISADE CAPITAL MANAGEMENT, LP | 501,672 | $5,924,746 | 0.16% |
CORNERCAP INVESTMENT COUNSEL INC | 67,457 | $796,667 | 0.14% |
Edgestream Partners, L.P. | 94,553 | $1,116,671 | 0.13% |
OCCUDO QUANTITATIVE STRATEGIES LP | 86,569 | $1,022,380 | 0.12% |
DUALITY ADVISERS, LP | 77,298 | $912,889 | 0.10% |
JACOBS LEVY EQUITY MANAGEMENT, INC | 1,253,042 | $14,798,427 | 0.10% |